;
Skip to main content
Home > BioCentury on BioBusiness > Analysts

Chronological Index of : Analyst Picks & Changes

 Current Issue
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/7 cls Biogen Idec Inc. (NASDAQ:BIIB) BMO Capital Markets Jim Birchenough Upgrade Outperform (from market perform) -4% $328.75 …

    Published on 3/10/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/28 cls Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Maxim Group Echo He Upgrade Buy (from hold) -2% $8.69 Echo He upgraded and set an $…

    Published on 3/3/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/21 cls NPS Pharmaceuticals Inc. (NASDAQ:NPSP) Jefferies Eun Yang Downgrade Hold (from buy) 4% $38.57 Yang downgraded on valuation …

    Published on 2/24/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/14 cls Depomed Inc. (NASDAQ:DEPO) Roth Capital Partners Scott Henry Downgrade Neutral (from buy) 1% $12.30 Henry downgraded on the …

    Published on 2/17/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/7 cls Fluidigm Corp. (NASDAQ:FLDM) Cowen Doug Schenkel Downgrade Market perform (from outperform) -4% $43.11 Schenkel raised his …

    Published on 2/10/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/31 cls BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Wells Fargo Brian Abrahams Downgrade Market perform (from outperform) -12% $10.20…

    Published on 2/3/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/17 cls AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) Jefferies Eun Yang Upgrade Hold (from underperform) -3% $21.01 Ladenburg Thalmann …

    Published on 1/27/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/17 cls Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) Leerink Partners Marko Kozul Price target Outperform 32% $87.36 Kozul raised his …

    Published on 1/20/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/10 cls Exelixis Inc. (NASDAQ:EXEL) Piper Jaffray Edward Tenthoff Upgrade Overweight (from neutral) 21% $7.44 Tenthoff also raised …

    Published on 1/13/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/3 cls Coronado Biosciences Inc. (NASDAQ:CNDO) Oppenheimer Boris Peaker Downgrade Market perform (from outperform) 1% $2.78 Peaker …

    Published on 1/6/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/20 cls Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) RBC Capital Markets Adnan Butt Downgrade Underperform (from sector performer) -1% $1…

    Published on 12/23/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/13 cls Ambit Biosciences Corp. (NASDAQ:AMBI) BMO Capital Markets Jim Birchenough Upgrade Outperform (from market perform) 20% $9.66…

    Published on 12/16/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/6 cls Biogen Idec Inc. (NASDAQ:BIIB) Bernstein Research Geoffrey Porges Price target Market perform 0% $290.90 Leerink Marko …

    Published on 12/9/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/22 cls Aerie Pharmaceuticals Inc. (NASDAQ:AERI) Canaccord Ritu Baral New Buy 9% $11.64 Baral initiated coverage with a $19 target,…

    Published on 11/25/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/15 cls Cellular Dynamics International Inc. (NASDAQ:ICEL) Leerink Dan Leonard Downgrade Market perform (from outperform) -5% $14.79…

    Published on 11/18/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/8 cls Curis Inc. (NASDAQ:CRIS) BMO Capital Markets Jim Birchenough Downgrade Market perform (from outperform) -30% $2.75 …

    Published on 11/11/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/1 cls Alimera Sciences Inc. (NASDAQ:ALIM) Cowen Simos Simeonidis Upgrade Outperform (from market perform) 1% $2.05 Simeonidis said…

    Published on 11/4/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/25 cls Amicus Therapeutics Inc. (NASDAQ:FOLD) Leerink Joseph Schwartz Downgrade Market perform (from market outperform) -5% $2.27 …

    Published on 10/28/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/118 cls AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) Baird Christopher Raymond Upgrade Outperform (from neutral) 8% $21.53 Raymond also…

    Published on 10/21/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/11 cls Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Barclays Capital Ying Huang Downgrade Underweight (from overweight) -77% $4.26 …

    Published on 10/14/2013
  • Analyst picks & changes

    Analyst picks & changes Wk 10/4 Company Bank Analyst Coverage Opinion chg cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Baird Brian Skorney Downgrade Neutral (from outperform) -62% $2.72 Deutsche …

    Published on 10/7/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/20 cls Celldex Therapeutics Inc. (NASDAQ:CLDX) Leerink Howard Liang Price target Outperform 24% $36.01 Liang raised his target to $…

    Published on 9/30/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/20 cls BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stifel Nicolaus Stephen Willey Downgrade Hold (from buy) 9% $76.95 Willey …

    Published on 9/23/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/13 cls Advanced Cell Technology Inc. (OTCBB:ACTC) Maxim Group Jason Kolbert New Buy 7% $0.06 Kolbert initiated coverage with a $0.…

    Published on 9/16/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/6 cls Pharmacyclics Inc. (NASDAQ:PCYC) Lazard Joshua Schimmer Upgrade Buy (from neutral) 6% $117.74 Schimmer also set a $141 target…

    Published on 9/9/2013

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993